# OnCo record guangzhou-virotech (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/guangzhou-virotech/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "guangzhou-virotech" ;
  schema:name "Guangzhou Virotech Pharmaceutical"@en ;
  schema:alternateName "Guangzhou Virotech Pharmaceutical Co., Ltd."@en ;
  schema:description "Guangzhou Virotech Pharmaceutical is a China-based biotechnology company that leads 2 cancer trials in OnCo, testing the M1 alphavirus-based oncolytic virus VRT106 in glioma & glioblastoma and diffuse midline glioma, H3 K27-altered."@en ;
  schema:url <https://onco.cc/companies/guangzhou-virotech/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?lead=Guangzhou%20Virotech%20Pharmaceutical%20Co.%2C%20Ltd.> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "CN" ;
  onco:cancers <https://onco.cc/cancers/glioblastoma/>, <https://onco.cc/cancers/dipg-dmg/> ;
  onco:trials <https://onco.cc/trials/nct07093814/>, <https://onco.cc/trials/nct07589257/> .